Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Receivables (2016 - 2025)

Historic Receivables for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 15 years, with Q2 2025 value amounting to $22.1 million.

  • Lifecore Biomedical, Inc. \De\'s Receivables rose 878.43% to $22.1 million in Q2 2025 from the same period last year, while for May 2025 it was $22.1 million, marking a year-over-year increase of 878.43%. This contributed to the annual value of $22.1 million for FY2025, which is 3841.32% down from last year.
  • Per Lifecore Biomedical, Inc. \De\'s latest filing, its Receivables stood at $22.1 million for Q2 2025, which was up 878.43% from $22.3 million recorded in Q1 2025.
  • Lifecore Biomedical, Inc. \De\'s Receivables' 5-year high stood at $53.6 million during Q1 2022, with a 5-year trough of $20.0 million in Q3 2023.
  • Over the past 5 years, Lifecore Biomedical, Inc. \De\'s median Receivables value was $33.9 million (recorded in 2023), while the average stood at $33.0 million.
  • As far as peak fluctuations go, Lifecore Biomedical, Inc. \De\'s Receivables tumbled by 6280.66% in 2021, and later skyrocketed by 6121.54% in 2024.
  • Quarter analysis of 5 years shows Lifecore Biomedical, Inc. \De\'s Receivables stood at $40.1 million in 2021, then decreased by 10.57% to $35.9 million in 2022, then crashed by 37.72% to $22.3 million in 2023, then soared by 61.22% to $36.0 million in 2024, then tumbled by 38.53% to $22.1 million in 2025.
  • Its Receivables stands at $22.1 million for Q2 2025, versus $22.3 million for Q1 2025 and $36.0 million for Q4 2024.